Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Perspective
  • Published:

Genetics of extreme human longevity to guide drug discovery for healthy ageing

Nature Metabolism volume 2, pages 663–672 (2020)Cite this article

Subjects

Abstract

Ageing is the greatest risk factor for most common chronic human diseases, and it therefore is a logical target for developing interventions to prevent, mitigate or reverse multiple age-related morbidities. Over the past two decades, genetic and pharmacologic interventions targeting conserved pathways of growth and metabolism have consistently led to substantial extension of the lifespan and healthspan in model organisms as diverse as nematodes, flies and mice. Recent genetic analysis of long-lived individuals is revealing common and rare variants enriched in these same conserved pathways that significantly correlate with longevity. In this Perspective, we summarize recent insights into the genetics of extreme human longevity and propose the use of this rare phenotype to identify genetic variants as molecular targets for gaining insight into the physiology of healthy ageing and the development of new therapies to extend the human healthspan.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Examples of conserved pathways of ageing.
Fig. 2: Genetic architecture of human ageing.
Fig. 3: Discovery of causal variants and genes in genetic studies of complex human traits.
Fig. 4: An integrated approach to drug discovery for healthy human ageing, on the basis of the genomic analysis of extreme longevity.
Fig. 5: Schematic illustration of the InPOINT pipeline.

Similar content being viewed by others

References

  1. World Population Ageing 2017 (United Nations, 2017).

  2. Partridge, L., Deelen, J. & Slagboom, P. E. Facing up to the global challenges of ageing. Nature 561, 45–56 (2018).

    Article  CAS  PubMed  Google Scholar 

  3. Barnett, K. et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 380, 37–43 (2012).

    Article  PubMed  Google Scholar 

  4. Marengoni, A. et al. Aging with multimorbidity: a systematic review of the literature. Ageing Res. Rev. 10, 430–439 (2011).

    Article  PubMed  Google Scholar 

  5. Goldman, D. The economic promise of delayed aging. Cold Spring Harb. Perspect. Med. 6, a025072 (2015).

    Article  PubMed  Google Scholar 

  6. Fontana, L., Partridge, L. & Longo, V. D. Extending healthy life span: from yeast to humans. Science 328, 321–326 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. van der Spoel, E. et al. Association analysis of insulin-like growth factor-1 axis parameters with survival and functional status in nonagenarians of the Leiden Longevity Study. Aging (Albany N.Y.) 7, 956–963 (2015).

    Google Scholar 

  8. Passtoors, W. M. et al. Gene expression analysis of mTOR pathway: association with human longevity. Aging Cell 12, 24–31 (2013).

    Article  CAS  PubMed  Google Scholar 

  9. Kenyon, C., Chang, J., Gensch, E., Rudner, A. & Tabtiang, R. A C. elegans mutant that lives twice as long as wild type. Nature 366, 461–464 (1993).

    Article  CAS  PubMed  Google Scholar 

  10. Fontana, L. & Partridge, L. Promoting health and longevity through diet: from model organisms to humans. Cell 161, 106–118 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Vellai, T. et al. Genetics: influence of TOR kinase on lifespan in C. elegans. Nature 426, 620 (2003).

    Article  CAS  PubMed  Google Scholar 

  12. Kapahi, P. et al. Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway. Curr. Biol. 14, 885–890 (2004).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Johnson, S. C. et al. mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome. Science 342, 1524–1528 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Zhang, Q. et al. Systems-level analysis of human aging genes shed new light on mechanisms of aging. Hum. Mol. Genet. 25, 2934–2947 (2016).

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Johnson, S. C., Rabinovitch, P. S. & Kaeberlein, M. mTOR is a key modulator of ageing and age-related disease. Nature 493, 338–345 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Harrison, D. E. et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460, 392–395 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Wilkinson, J. E. et al. Rapamycin slows aging in mice. Aging Cell 11, 675–682 (2012).

    Article  CAS  PubMed  Google Scholar 

  18. Bjedov, I. et al. Mechanisms of life span extension by rapamycin in the fruit fly Drosophila melanogaster. Cell Metab. 11, 35–46 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Powers, R. W. III, Kaeberlein, M., Caldwell, S. D., Kennedy, B. K. & Fields, S. Extension of chronological life span in yeast by decreased TOR pathway signaling. Genes Dev. 20, 174–184 (2006).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Robida-Stubbs, S. et al. TOR signaling and rapamycin influence longevity by regulating SKN-1/Nrf and DAF-16/FoxO. Cell Metab. 15, 713–724 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Miller, R. A. et al. An Aging Interventions Testing Program: study design and interim report. Aging Cell 6, 565–575 (2007).

    Article  CAS  PubMed  Google Scholar 

  22. Nadon, N. L. et al. Design of aging intervention studies: the NIA interventions testing program. Age (Dordr.) 30, 187–199 (2008).

    Article  CAS  Google Scholar 

  23. Harrison, D. E. et al. Acarbose, 17-α-estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males. Aging Cell 13, 273–282 (2014).

    Article  CAS  PubMed  Google Scholar 

  24. Barzilai, N., Crandall, J. P., Kritchevsky, S. B. & Espeland, M. A. Metformin as a tool to target aging. Cell Metab. 23, 1060–1065 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Justice, J. N. et al. Development of clinical trials to extend healthy lifespan. Cardiovasc Endocrinol Metab 7, 80–83 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  26. de Magalhães, J. P. Why genes extending lifespan in model organisms have not been consistently associated with human longevity and what it means to translation research. Cell Cycle 13, 2671–2673 (2014).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  27. Johnson, S. C., Dong, X., Vijg, J. & Suh, Y. Genetic evidence for common pathways in human age-related diseases. Aging Cell 14, 809–817 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Perls, T. T., Bubrick, E., Wager, C. G., Vijg, J. & Kruglyak, L. Siblings of centenarians live longer. Lancet 351, 1560 (1998).

    Article  CAS  PubMed  Google Scholar 

  29. Schoenmaker, M. et al. Evidence of genetic enrichment for exceptional survival using a family approach: the Leiden Longevity Study. Eur. J. Hum. Genet. 14, 79–84 (2006).

    Article  PubMed  Google Scholar 

  30. Herskind, A. M. et al. The heritability of human longevity: a population-based study of 2872 Danish twin pairs born 1870-1900. Hum. Genet. 97, 319–323 (1996).

    Article  CAS  PubMed  Google Scholar 

  31. Christensen, K., Johnson, T. E. & Vaupel, J. W. The quest for genetic determinants of human longevity: challenges and insights. Nat. Rev. Genet. 7, 436–448 (2006).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Murabito, J. M., Yuan, R. & Lunetta, K. L. The search for longevity and healthy aging genes: insights from epidemiological studies and samples of long-lived individuals. J. Gerontol. A Biol. Sci. Med. Sci. 67, 470–479 (2012).

    Article  PubMed  CAS  Google Scholar 

  33. Perls, T. T. et al. Life-long sustained mortality advantage of siblings of centenarians. Proc. Natl Acad. Sci. USA 99, 8442–8447 (2002).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Robine, J. M. & Allard, M. The oldest human. Science 279, 1834–1835 (1998).

    Article  CAS  PubMed  Google Scholar 

  35. Gögele, M. et al. Heritability analysis of life span in a semi-isolated population followed across four centuries reveals the presence of pleiotropy between life span and reproduction. J. Gerontol. A Biol. Sci. Med. Sci. 66, 26–37 (2011).

    Article  PubMed  Google Scholar 

  36. van den Berg, N. et al. Longevity defined as top 10% survivors and beyond is transmitted as a quantitative genetic trait. Nat. Commun. 10, 35 (2019).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  37. Barzilai, N., Gabriely, I., Gabriely, M., Iankowitz, N. & Sorkin, J. D. Offspring of centenarians have a favorable lipid profile. J. Am. Geriatr. Soc. 49, 76–79 (2001).

    Article  CAS  PubMed  Google Scholar 

  38. Newman, A. B. et al. Health and function of participants in the Long Life Family Study: a comparison with other cohorts. Aging (Albany N.Y.) 3, 63–76 (2011).

    Google Scholar 

  39. Deelen, J. et al. Employing biomarkers of healthy ageing for leveraging genetic studies into human longevity. Exp. Gerontol. 82, 166–174 (2016).

    Article  CAS  PubMed  Google Scholar 

  40. Ash, A. S. et al. Are members of long-lived families healthier than their equally long-lived peers? Evidence from the Long Life Family Study. J. Gerontol. A Biol. Sci. Med. Sci. 70, 971–976 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  41. Ruby, J. G. et al. Estimates of the heritability of human longevity are substantially inflated due to assortative mating. Genetics 210, 1109–1124 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  42. Jarry, V., Gagnon, A. & Bourbeau, R. Survival advantage of siblings and spouses of centenarians in 20th-century Quebec. Can. Stud. Popul. 39, 67–78 (2012).

    Article  Google Scholar 

  43. van den Berg, N. et al. Longevity Relatives Count score identifies heritable longevity carriers and suggests case improvement in genetic studies. Aging Cell 19, e13139 (2020).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  44. McDaid, A. F. et al. Bayesian association scan reveals loci associated with human lifespan and linked biomarkers. Nat. Commun. 8, 15842 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Zenin, A. et al. Identification of 12 genetic loci associated with human healthspan. Commun. Biol. 2, 41 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  46. Fernandes, M. et al. Systematic analysis of the gerontome reveals links between aging and age-related diseases. Hum. Mol. Genet. 25, 4804–4818 (2016).

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Shindyapina, A. V. et al. Germline burden of rare damaging variants negatively affects human healthspan and lifespan. eLife 9, e53449 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  48. Cash, T. P. et al. Exome sequencing of three cases of familial exceptional longevity. Aging Cell 13, 1087–1090 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Nygaard, H. B. et al. Whole exome sequencing of an exceptional longevity cohort. J. Gerontol. A Biol. Sci. Med. Sci. 74, 1386–1390 (2019).

    Article  CAS  PubMed  Google Scholar 

  50. Han, J. et al. Discovery of novel non-synonymous SNP variants in 988 candidate genes from 6 centenarians by target capture and next-generation sequencing. Mech. Ageing Dev. 134, 478–485 (2013).

    Article  CAS  PubMed  Google Scholar 

  51. Howden, L. M. & Meyer, J. A. Age and Sex Composition: 2010 (U.S. Census Bureau, 2011).

  52. Andersen, S. L., Sebastiani, P., Dworkis, D. A., Feldman, L. & Perls, T. T. Health span approximates life span among many supercentenarians: compression of morbidity at the approximate limit of life span. J. Gerontol. A Biol. Sci. Med. Sci. 67, 395–405 (2012).

    Article  PubMed  Google Scholar 

  53. Ismail, K. et al. Compression of morbidity is observed across cohorts with exceptional longevity. J. Am. Geriatr. Soc. 64, 1583–1591 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  54. Sebastiani, P. et al. Families enriched for exceptional longevity also have increased health-span: findings from the Long Life Family Study. Front. Public Health 1, 38 (2013).

    Article  PubMed  PubMed Central  Google Scholar 

  55. Hazra, N. C., Rudisill, C. & Gulliford, M. C. Determinants of health care costs in the senior elderly: age, comorbidity, impairment, or proximity to death? Eur. J. Health Econ. 19, 831–842 (2018).

    Article  PubMed  Google Scholar 

  56. Abifadel, M. et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat. Genet. 34, 154–156 (2003).

    Article  CAS  PubMed  Google Scholar 

  57. Zhao, Z. et al. Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote. Am. J. Hum. Genet. 79, 514–523 (2006).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Hooper, A. J., Marais, A. D., Tanyanyiwa, D. M. & Burnett, J. R. The C679X mutation in PCSK9 is present and lowers blood cholesterol in a Southern African population. Atherosclerosis 193, 445–448 (2007).

    Article  CAS  PubMed  Google Scholar 

  59. Fitzgerald, K. et al. Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial. Lancet 383, 60–68 (2014).

    Article  CAS  PubMed  Google Scholar 

  60. Ridker, P. M. et al. Cardiovascular efficacy and safety of bococizumab in high-risk patients. N. Engl. J. Med. 376, 1527–1539 (2017).

    Article  CAS  PubMed  Google Scholar 

  61. Tall, A. R. & Rader, D. J. Trials and tribulations of CETP inhibitors. Circ. Res. 122, 106–112 (2018).

    Article  CAS  PubMed  Google Scholar 

  62. Goodwin, S., McPherson, J. D. & McCombie, W. R. Coming of age: ten years of next-generation sequencing technologies. Nat. Rev. Genet. 17, 333–351 (2016).

    Article  CAS  PubMed  Google Scholar 

  63. Gorlov, I. P., Gorlova, O. Y., Sunyaev, S. R., Spitz, M. R. & Amos, C. I. Shifting paradigm of association studies: value of rare single-nucleotide polymorphisms. Am. J. Hum. Genet. 82, 100–112 (2008).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Kosmicki, J. A., Churchhouse, C. L., Rivas, M. A. & Neale, B. M. Discovery of rare variants for complex phenotypes. Hum. Genet. 135, 625–634 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  65. Nicolae, D. L. Association tests for rare variants. Annu. Rev. Genomics Hum. Genet. 17, 117–130 (2016).

    Article  CAS  PubMed  Google Scholar 

  66. Finan, C. et al. The druggable genome and support for target identification and validation in drug development. Sci. Transl. Med. 9, eaag1166 (2017).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  67. Oprea, T. I. et al. Unexplored therapeutic opportunities in the human genome. Nat. Rev. Drug Discov. 17, 317–332 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Plenge, R. M., Scolnick, E. M. & Altshuler, D. Validating therapeutic targets through human genetics. Nat. Rev. Drug Discov. 12, 581–594 (2013).

    Article  CAS  PubMed  Google Scholar 

  69. Tazearslan, C., Huang, J., Barzilai, N. & Suh, Y. Impaired IGF1R signaling in cells expressing longevity-associated human IGF1R alleles. Aging Cell 10, 551–554 (2011).

    Article  CAS  PubMed  Google Scholar 

  70. Suh, Y. et al. Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proc. Natl Acad. Sci. USA 105, 3438–3442 (2008).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Mao, K. et al. Late-life targeting of the IGF-1 receptor improves healthspan and lifespan in female mice. Nat. Commun. 9, 2394 (2018).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  72. Vidal, M., Cusick, M. E. & Barabasi, A. L. Interactome networks and human disease. Cell 144, 986–998 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Barabasi, A. L., Gulbahce, N. & Loscalzo, J. Network medicine: a network-based approach to human disease. Nat. Rev. Genet. 12, 56–68 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Pawson, T. & Nash, P. Protein-protein interactions define specificity in signal transduction. Genes Dev. 14, 1027–1047 (2000).

    CAS  PubMed  Google Scholar 

  75. Wang, X. et al. Three-dimensional reconstruction of protein networks provides insight into human genetic disease. Nat. Biotechnol. 30, 159–164 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Stenson, P. D. et al. Human Gene Mutation Database (HGMD): 2003 update. Hum. Mutat. 21, 577–581 (2003).

    Article  CAS  PubMed  Google Scholar 

  77. Khurana, E. et al. Integrative annotation of variants from 1092 humans: application to cancer genomics. Science 342, 1235587 (2013).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  78. Guo, Y. et al. Dissecting disease inheritance modes in a three-dimensional protein network challenges the “guilt-by-association” principle. Am. J. Hum. Genet. 93, 78–89 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Wei, X. et al. A massively parallel pipeline to clone DNA variants and examine molecular phenotypes of human disease mutations. PLoS Genet. 10, e1004819 (2014).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  80. Chen, S. et al. An interactome perturbation framework prioritizes damaging missense mutations for developmental disorders. Nat. Genet. 50, 1032–1040 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Braun, P. et al. An experimentally derived confidence score for binary protein-protein interactions. Nat. Meth. 6, 91–97 (2009).

    Article  CAS  Google Scholar 

  82. Yu, H. et al. High-quality binary protein interaction map of the yeast interactome network. Science 322, 104–110 (2008).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Yu, H. et al. Next-generation sequencing to generate interactome datasets. Nat. Methods 8, 478–480 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Sahni, N. et al. Widespread macromolecular interaction perturbations in human genetic disorders. Cell 161, 647–660 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  85. Zhong, Q. et al. Edgetic perturbation models of human inherited disorders. Mol. Syst. Biol. 5, 321 (2009).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  86. Fabrizio, P., Pozza, F., Pletcher, S. D., Gendron, C. M. & Longo, V. D. Regulation of longevity and stress resistance by Sch9 in yeast. Science 292, 288–290 (2001).

    Article  CAS  PubMed  Google Scholar 

  87. Wang, H. D., Kazemi-Esfarjani, P. & Benzer, S. Multiple-stress analysis for isolation of Drosophila longevity genes. Proc. Natl Acad. Sci. USA 101, 12610–12615 (2004).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  88. Muñoz, M. J. & Riddle, D. L. Positive selection of Caenorhabditis elegans mutants with increased stress resistance and longevity. Genetics 163, 171–180 (2003).

    PubMed  PubMed Central  Google Scholar 

  89. de Magalhães, J. P. & Toussaint, O. GenAge: a genomic and proteomic network map of human ageing. FEBS Lett. 571, 243–247 (2004).

    Article  PubMed  CAS  Google Scholar 

  90. Soldner, F. & Jaenisch, R. Stem cells, genome editing, and the path to translational medicine. Cell 175, 615–632 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  91. Lo Sardo, V. et al. Unveiling the role of the most impactful cardiovascular risk locus through haplotype editing. Cell 175, 1796–1810.e1720 (2018).

    Article  CAS  PubMed  Google Scholar 

  92. Aguiar-Oliveira, M. H. & Bartke, A. Growth hormone deficiency: health and longevity. Endocr. Rev. 40, 575–601 (2019).

    Article  PubMed  Google Scholar 

  93. Tilstra, J. S. et al. NF-κB inhibition delays DNA damage-induced senescence and aging in mice. J. Clin. Invest. 122, 2601–2612 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  94. Niedernhofer, L. J. et al. A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis. Nature 444, 1038–1043 (2006).

    Article  CAS  PubMed  Google Scholar 

  95. Hambright, W. S., Niedernhofer, L. J., Huard, J. & Robbins, P. D. Murine models of accelerated aging and musculoskeletal disease. Bone 125, 122–127 (2019).

    Article  CAS  PubMed  Google Scholar 

  96. Willcox, B. J. et al. FOXO3A genotype is strongly associated with human longevity. Proc. Natl Acad. Sci. USA 105, 13987–13992 (2008).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Morris, B. J., Willcox, D. C., Donlon, T. A. & Willcox, B. J. FOXO3: a major gene for human longevity: a mini-review. Gerontology 61, 515–525 (2015).

    Article  CAS  PubMed  Google Scholar 

  98. Cautain, B. et al. Discovery of a novel, isothiazolonaphthoquinone-based small molecule activator of FOXO nuclear-cytoplasmic shuttling. PLoS ONE 11, e0167491 (2016).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  99. Belguise, K., Guo, S. & Sonenshein, G. E. Activation of FOXO3a by the green tea polyphenol epigallocatechin-3-gallate induces estrogen receptor alpha expression reversing invasive phenotype of breast cancer cells. Cancer Res. 67, 5763–5770 (2007).

    Article  CAS  PubMed  Google Scholar 

  100. Cho, S. et al. Syringaresinol protects against hypoxia/reoxygenation-induced cardiomyocytes injury and death by destabilization of HIF-1α in a FOXO3-dependent mechanism. Oncotarget 6, 43–55 (2015).

    Article  PubMed  Google Scholar 

  101. Bowman, L. et al. Effects of anacetrapib in patients with atherosclerotic vascular disease. N. Engl. J. Med. 377, 1217–1227 (2017).

    Article  PubMed  Google Scholar 

  102. Hall, S. S. Genetics: a gene of rare effect. Nature 496, 152–155 (2013).

    Article  CAS  PubMed  Google Scholar 

  103. Rajpathak, S. N. et al. Lifestyle factors of people with exceptional longevity. J. Am. Geriatr. Soc. 59, 1509–1512 (2011).

    Article  PubMed  PubMed Central  Google Scholar 

  104. Bitto, A., Wang, A. M., Bennett, C. F. & Kaeberlein, M. Biochemical genetic pathways that modulate aging in multiple species. Cold Spring Harb. Perspect. Med. 5, a025114 (2015).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  105. Taniguchi, C. M., Emanuelli, B. & Kahn, C. R. Critical nodes in signalling pathways: insights into insulin action. Nat. Rev. Mol. Cell Biol. 7, 85–96 (2006).

    Article  CAS  PubMed  Google Scholar 

  106. Kennedy, B. K. & Lamming, D. W. The mechanistic target of rapamycin: the grand conductor of metabolism and aging. Cell Metab. 23, 990–1003 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  107. Kahn, A. J. FOXO3 and related transcription factors in development, aging, and exceptional longevity. J. Gerontol. A Biol. Sci. Med. Sci. 70, 421–425 (2015).

    Article  CAS  PubMed  Google Scholar 

  108. Roczniak-Ferguson, A. et al. The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis. Sci. Signal. 5, ra42 (2012).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  109. Mammucari, C. et al. FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab. 6, 458–471 (2007).

    Article  CAS  PubMed  Google Scholar 

  110. Kops, G. J. et al. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 419, 316–321 (2002).

    Article  CAS  PubMed  Google Scholar 

  111. Greer, E. L. et al. The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor. J. Biol. Chem. 282, 30107–30119 (2007).

    Article  CAS  PubMed  Google Scholar 

  112. Cantó, C. et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458, 1056–1060 (2009).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  113. Brunet, A. et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303, 2011–2015 (2004).

    Article  CAS  PubMed  Google Scholar 

  114. Yeung, F. et al. Modulation of NF-κB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 23, 2369–2380 (2004).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  115. Tasselli, L., Zheng, W. & Chua, K. F. SIRT6: novel mechanisms and links to aging and disease. Trends Endocrinol. Metab. 28, 168–185 (2017).

    Article  CAS  PubMed  Google Scholar 

  116. Roichman, A. et al. SIRT6 overexpression improves various aspects of mouse healthspan. J. Gerontol. A Biol. Sci. Med. Sci. 72, 603–615 (2017).

    CAS  PubMed  Google Scholar 

  117. Tian, X. et al. SIRT6 is responsible for more efficient DNA double-strand break repair in long-lived species. Cell 177, 622–638.e622 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  118. Di Francesco, A., Di Germanio, C., Bernier, M. & de Cabo, R. A time to fast. Science 362, 770–775 (2018).

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  119. Mannick, J. B. et al. mTOR inhibition improves immune function in the elderly. Sci. Transl. Med. 6, 268ra179 (2014).

    Article  PubMed  CAS  Google Scholar 

  120. Timmers, S. et al. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab. 14, 612–622 (2011).

    Article  CAS  PubMed  Google Scholar 

  121. Dai, H., Sinclair, D. A., Ellis, J. L. & Steegborn, C. Sirtuin activators and inhibitors: promises, achievements, and challenges. Pharmacol. Ther. 188, 140–154 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  122. van Heemst, D. et al. Reduced insulin/IGF-1 signalling and human longevity. Aging Cell 4, 79–85 (2005).

    Article  PubMed  CAS  Google Scholar 

  123. Milman, S. et al. Low insulin-like growth factor-1 level predicts survival in humans with exceptional longevity. Aging Cell 13, 769–771 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  124. Deelen, J. et al. Gene set analysis of GWAS data for human longevity highlights the relevance of the insulin/IGF-1 signaling and telomere maintenance pathways. Age (Dordr.) 35, 235–249 (2013).

    Article  CAS  Google Scholar 

  125. Pawlikowska, L. et al. Association of common genetic variation in the insulin/IGF1 signaling pathway with human longevity. Aging Cell 8, 460–472 (2009).

    Article  CAS  PubMed  Google Scholar 

  126. Kichaev, G. et al. Integrating functional data to prioritize causal variants in statistical fine-mapping studies. PLoS Genet. 10, e1004722 (2014).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  127. Hormozdiari, F. et al. Colocalization of GWAS and eQTL signals detects target genes. Am. J. Hum. Genet. 99, 1245–1260 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  128. Gusev, A. et al. Integrative approaches for large-scale transcriptome-wide association studies. Nat. Genet. 48, 245–252 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  129. Holmans, P. et al. Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder. Am. J. Hum. Genet. 85, 13–24 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  130. Jia, P., Zheng, S., Long, J., Zheng, W. & Zhao, Z. dmGWAS: dense module searching for genome-wide association studies in protein-protein interaction networks. Bioinformatics 27, 95–102 (2011).

    Article  CAS  PubMed  Google Scholar 

  131. de Leeuw, C. A., Mooij, J. M., Heskes, T. & Posthuma, D. MAGMA: generalized gene-set analysis of GWAS data. PLOS Comput. Biol. 11, e1004219 (2015).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  132. Taşan, M. et al. Selecting causal genes from genome-wide association studies via functionally coherent subnetworks. Nat. Methods 12, 154–159 (2015).

    Article  PubMed  CAS  Google Scholar 

  133. Lin, J. R. et al. PGA: post-GWAS analysis for disease gene identification. Bioinformatics 34, 1786–1788 (2018).

    Article  CAS  PubMed  Google Scholar 

  134. Lin, J. R. et al. Integrated Post-GWAS analysis sheds new light on the disease mechanisms of schizophrenia. Genetics 204, 1587–1600 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  135. Kircher, M. et al. A general framework for estimating the relative pathogenicity of human genetic variants. Nat. Genet. 46, 310–315 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  136. Sundaram, L. et al. Predicting the clinical impact of human mutation with deep neural networks. Nat. Genet. 50, 1161–1170 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  137. Lin, J. R., Zhang, Q., Cai, Y., Morrow, B. E. & Zhang, Z. D. Integrated rare variant-based risk gene prioritization in disease case-control sequencing studies. PLoS Genet. 13, e1007142 (2017).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  138. Landrum, M. J. et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 42, D980–D985 (2014).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank M. Guo and R. Kohanski at NIA for their scientific input, which contributed to the concepts outlined in this Perspective. This work was supported by grant U19 AG056278 from the US National Institutes of Health.

Author information

Authors and Affiliations

  1. Department of Genetics, Albert Einstein College of Medicine, New York, NY, USA

    Zhengdong D. Zhang, Sofiya Milman, Jhih-Rong Lin, Nir Barzilai, Yousin Suh & Jan Vijg

  2. Department of Medicine, Albert Einstein College of Medicine, New York, NY, USA

    Sofiya Milman & Nir Barzilai

  3. Department of Computational Biology, Weill Institute for Cell and Molecular Biology, Cornell University, New York, NY, USA

    Shayne Wierbowski & Haiyuan Yu

  4. Department of Biology, University of Rochester, Rochester, NY, USA

    Vera Gorbunova

  5. Department of Comparative Medicine, School of Medicine, University of Washington, Seattle, WA, USA

    Warren C. Ladiges

  6. Institute on the Biology of Aging and Metabolism and Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, MN, USA

    Laura J. Niedernhofer & Paul D. Robbins

  7. Departments of Obstetrics and Gynecology, Genetics and Development, Columbia University, New York, NY, USA

    Yousin Suh

  8. Center for Single-Cell Omics in Aging and Disease, School of Public Health, Shanghai, Jiao Tong University School of Medicine, Shanghai, China

    Jan Vijg

Authors
  1. Zhengdong D. Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sofiya Milman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jhih-Rong Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shayne Wierbowski
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Haiyuan Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Nir Barzilai
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Vera Gorbunova
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Warren C. Ladiges
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Laura J. Niedernhofer
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Yousin Suh
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Paul D. Robbins
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Jan Vijg
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Z.D.Z., V.G., W.C.L., L.J.N., Y.S., P.D.R. and J.V. substantially contributed to the discussion and the writing of the content. Z.D.Z., S.M., J.-R.L., S.W., H.Y., N.B., V.G., W.C.L., L.J.N., Y.S., P.D.R. and J.V. researched content for the article, contributed to writing, and reviewed and edited the manuscript before submission.

Corresponding author

Correspondence to Zhengdong D. Zhang.

Ethics declarations

Competing interests

J.V. is a founder of Singulomics Corp. P.R. and L.N. are co-founders of NRTK Biosciences. All other authors declare no competing interests.

Additional information

Peer review information Primary Handling Editor: Pooja Jha.

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Supplementary Information

Supplementary Tables 1 and 2

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, Z.D., Milman, S., Lin, JR. et al. Genetics of extreme human longevity to guide drug discovery for healthy ageing. Nat Metab 2, 663–672 (2020). https://doi.org/10.1038/s42255-020-0247-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s42255-020-0247-0

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research